GSE119369 H10 inhibition 1 v 6 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE119369_H10 inhibition_1_v_6_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE119369_H10 inhibition_1_v_6_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE119369_H10 inhibition_1_v_6_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE119369_H10 inhibition_1_v_6_human_up.

Results found

Linked to

 

Label

Description

 

Gene

GOLGA2 pseudogene 7

Gene

long intergenic non-protein coding RNA 511

Gene

VPS9D1 antisense RNA 1

Gene

transmembrane protein 198B (pseudogene)

Gene

FBXL19 antisense RNA 1

Gene

long intergenic non-protein coding RNA 3014

Gene

CCDC26 long non-coding RNA

Gene

long intergenic non-protein coding RNA 886

Gene

family with sequence similarity 86, member C

Gene

OTUD6B antisense RNA 1

  • Gene

    GOLGA2 pseudogene 7


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    transmembrane protein 198B (pseudogene)


  • Gene

    FBXL19 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 3014


  • Gene

    CCDC26 long non-coding RNA


  • Gene

    long intergenic non-protein coding RNA 886


  • Gene

    family with sequence similarity 86, member C


  • Gene

    OTUD6B antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.